RECURRENT CHILDHOOD OSTEOSARCOMA
Clinical trials for RECURRENT CHILDHOOD OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CHILDHOOD OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for RECURRENT CHILDHOOD OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists re-engineer Patients' own cells to hunt deadly childhood cancers
Disease control TerminatedThis early-stage study is testing a new cell therapy called GD2CART for children and young adults whose neuroblastoma or osteosarcoma has returned or not responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to recognize cancer, and inf…
Matched conditions: RECURRENT CHILDHOOD OSTEOSARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Targeted drug trial offers hope for kids with Tough-to-Treat cancers
Disease control OngoingThis study is testing a drug called erdafitinib in children and young adults with advanced cancers that have returned or not responded to standard treatments. It is for patients whose tumors have specific genetic changes (FGFR mutations). The goal is to see if the drug, which is …
Matched conditions: RECURRENT CHILDHOOD OSTEOSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC